1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow DIMS0150: new trials by email Literature Review of DIMS0150 trials Research Report on DIMS0150
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Efficacy and Safety of Cobitolimod (Kappaproct®) in Chronic Active Treatment Refractory Ulcerative Colitis Patients Cobitolimod, Placebo - Colitis, Ulcerative | Phase 3 | Completed | InDex Pharmaceuticals | 131 | 2011-12-01 | 2023-01-10 |
Colitis, Ulcerative (1) · Gastrointestinal Diseases (1) · Inflammatory Bowel Diseases (1)
Czechia (1) · France (1) · Germany (1) · Hungary (1) · Italy (1) · Poland (1) · United Kingdom (1)